Literature DB >> 10177763

Organ Procurement and Transplantation Network--HRSA. Final rule with comment period.

.   

Abstract

This document sets forth the final rule governing the operation of the Organ Procurement and Transplantation Network (OPTN), which performs a variety of functions related to organ transplantation under contract with HHS. The document also offers a 60 day period for additional public comment. The rule will become effective 30 days following the close of the comment period. If the Department believes that additional time is required to review the comments, we will consider delaying the effective date. In combination with a new National Organ and Tissue Donation Initiative, this rule is intended to improve the effectiveness and equity of the Nation's transplantation system and to further the purposes of the National Organ Transplant Act of 1984, as amended. These purposes include: encouraging organ donation; developing an organ allocation system that functions as much as technologically feasible on a nationwide basis; providing the bases for effective Federal oversight of the OPTN (as well as for implementing related provisions in the Social Security Act); and, providing better information about transplantation to patients, families and health care providers.

Entities:  

Keywords:  Health Care and Public Health; Legal Approach

Mesh:

Year:  1998        PMID: 10177763

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  23 in total

1.  Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma.

Authors:  David Goldberg; Benjamin French; Peter Abt; Sandy Feng; Andrew M Cameron
Journal:  Liver Transpl       Date:  2012-04       Impact factor: 5.799

2.  Using Bayesian networks to predict survival of liver transplant patients.

Authors:  Nathan Hoot; Dominik Aronsky
Journal:  AMIA Annu Symp Proc       Date:  2005

3.  Do report cards influence hospital choice? The case of kidney transplantation.

Authors:  David H Howard; Bruce Kaplan
Journal:  Inquiry       Date:  2006       Impact factor: 1.730

4.  Multiple listings as a reflection of geographic disparity in liver transplantation.

Authors:  Parsia A Vagefi; Sandy Feng; Jennifer L Dodge; James F Markmann; John P Roberts
Journal:  J Am Coll Surg       Date:  2014-05-02       Impact factor: 6.113

5.  Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease.

Authors:  A Cucchetti; M Vivarelli; N D Heaton; S Phillips; F Piscaglia; L Bolondi; G La Barba; M R Foxton; M Rela; J O'Grady; A D Pinna
Journal:  Gut       Date:  2006-06-29       Impact factor: 23.059

6.  Predicting Outcomes on the Liver Transplant Waiting List in the United States: Accounting for Large Regional Variation in Organ Availability and Priority Allocation Points.

Authors:  Allyson Hart; David P Schladt; Jessica Zeglin; Joshua Pyke; W Ray Kim; John R Lake; John P Roberts; Ryutaro Hirose; David C Mulligan; Bertram L Kasiske; Jon J Snyder; Ajay K Israni
Journal:  Transplantation       Date:  2016-10       Impact factor: 4.939

Review 7.  Liver Allocation Policies in the USA: Past, Present, and the Future.

Authors:  Anjana Pillai; Thomas Couri; Michael Charlton
Journal:  Dig Dis Sci       Date:  2019-04       Impact factor: 3.199

8.  Updates in the management of hepatocellular carcinoma.

Authors:  Robert Wong; Catherine Frenette
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-01

9.  Ethical and Logistical Issues Raised by the Advanced Donation Program "Pay It Forward" Scheme.

Authors:  Lainie Friedman Ross; James R Rodrigue; Robert M Veatch
Journal:  J Med Philos       Date:  2017-10-01

Review 10.  Kidney, pancreas and liver allocation and distribution in the United States.

Authors:  J M Smith; S W Biggins; D G Haselby; W R Kim; J Wedd; K Lamb; B Thompson; D L Segev; S Gustafson; R Kandaswamy; P G Stock; A J Matas; C J Samana; E F Sleeman; D Stewart; A Harper; E Edwards; J J Snyder; B L Kasiske; A K Israni
Journal:  Am J Transplant       Date:  2012-11-16       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.